News 09 Abr 2024 DESI project unveils groundbreaking 3D universe map with EPFL’s aid EPFL astrophysicists have contributed to creating the most detailed 3D map of the universe, tracing expansion over 11 billion years.
Aktuell 16 Abr 2024 QS führt Hälfte der Schweizer Studienfächer in weltweiten Top 100 Die Schweiz wird in der QS-Rangliste 2024 bei der Zahl ihrer Studienfächer, die sich weltweit in den Top 10 befinden, nur von den USA und Grossb...
News 07 Mar 2024 Jedsy cooperates with the TCS to insure drone deliveries Drone specialist Jedsy from the canton of St.Gallen has entered into a partnership with the Touring Club Switzerland (TCS) to insure drone delive...
Actualités 09 Abr 2024 Le projet DESI dévoile une carte 3D inédite de l’univers avec l’aide de l’EPFL Des astrophysiciens de l’EPFL ont contribué à la création de la carte 3D la plus détaillée de l’univers, retraçant son expansion sur 11 milliards...
Aktuell 14 Mar 2024 Drei Frauen werden mit dem SEF.WomenAward 2024 geehrt Das Swiss Economic Forum (SEF) hat die Preisträgerinnen des SEF.WomenAward 2024 geehrt: Alessia Schrepfer von der WeNurse AG als Jungunternehmeri...
News 10 Ene 2024 Using AI technology to identify unique chemical signatures of prestigious wines A team from the University of Geneva, in partnership with the University of Bordeaux, has achieved a significant breakthrough in wine science. Us...
Actualités 18 Mar 2024 be-advanced : un soutien aux entrepreneurs à Berne et au-delà En mettant l’accent sur le coaching en matière d’innovation pour les PME et les jeunes entreprises bernoises, be-advanced stimule l’esprit d’entr...
News 04 Ene 2024 Lucerne University of Applied Sciences and Arts to teach nursing at degree level Lucerne University of Applied Sciences and Arts will begin teaching degree-level nursing from the 2024 fall semester. It is also expanding its pr...
Aktuell 06 Feb 2024 FHNW und Industrie gehen Stromnetze der Zukunft gemeinsam an Die Hochschule für Technik FHNW und ihre Industriepartner Brugg Cables und PFIFFNER Gruppe haben das Netzwerk StromCircle gegründet. Es will sich...
Aktuell 14 Feb 2024 Tessin erhält Innovation Booster für Mode und Lifestyle Die Stadt Lugano, Dagorà Lifestyle Innovation Hub und der Switzerland Innovation Park Ticino haben gemeinsam ein Innovation Booster Programm für ...
News 29 Nov 2023 Meditron, EPFL’s new Large Language Model for medical knowledge EPFL researchers have unveiled Meditron, a groundbreaking open-source Large Language Model (LLM) specifically tailored for the medical field.
News 24 Nov 2023 The International School Sport Federation establishes headquarters in Lausanne Lausanne and the canton of Vaud are set to strengthen their global stature in international sports with the arrival of the International School S...
News 03 Nov 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News 27 Oct 2023 Stadler Rail named as the winner of the Avantgarde Award Stadler Rail has been named as the winner of the first-ever Avantgarde Award in Los Angeles. The rail vehicle manufacturing company based in the ...
News 20 Oct 2023 Xlife Sciences becomes main shareholder in 4D Lifetec Xlife Sciences, a listed accelerator and investor in innovative healthcare solutions, has made an investment totalling 23.3 million Swiss francs ...
News 18 Oct 2023 Deloitte and Nexxiot enter into strategic partnership for logistics Deloitte is the new integration partner for Nexxiot technology. The consulting firm combines its regulatory competencies with Nexxiot’s network c...
Actualités 14 Feb 2024 L’Université de Fribourg découvre un traitement pour combattre la neuroinflammation liée à l’âge Des scientifiques de l’Université de Fribourg ont découvert un mécanisme révolutionnaire qui pourrait atténuer de manière significative la neuroi...
News 10 Oct 2023 HES-SO Valais-Wallis and Debiopharm partner up to battle cancer HES-SO Valais-Wallis and Debiopharm have entered a partnership to advance targeted cancer therapy research with novel antibody conjugates.